´ëÇÑ´ç´¢º´ÇÐȸ The 22nd Postgraduate Course of Diabetes : 2023-11-18
±³À°ÀÏÀÚ : 2023-11-18
±³À°Àå¼Ò : aT¼¾ÅÍ 3Ãþ ¼¼°è·Î·ë (¼¿ï½Ã ¾çÀ絿 ¼ÒÀç)
±³À°ÁÖÁ¦ : The 22nd Postgraduate Course of Diabetes
ÁÖÃÖ±â°ü : ´ëÇÑ´ç´¢º´ÇÐȸ
´ã´çÀÚ : ±èÁ¤Èñ
¿¬¶ôó : 02-714-9081
À̸ÞÀÏ : diabetes@kams.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í "»çÀüµî·Ï : ºñȸ¿ø: ÀÇ»ç(Àü°øÀÇÁ¦¿Ü)- 6¸¸¿ø Àü°øÀÇ ¹× ºñÀÇ»ç- 4¸¸¿ø / ȸ¿ø: ÀÇ»ç(Àü°øÀÇÁ¦¿Ü)- 4¸¸¿ø ºñÀÇ»ç- 2¸¸¿ø Àü°øÀÇȸ¿ø- ¹«·á
´çÀϵî·Ï : ºñȸ¿ø: ÀÇ»ç(Àü°øÀÇÁ¦¿Ü)- 7¸¸¿ø Àü°øÀÇ ¹× ºñÀÇ»ç- 5¸¸¿ø / ȸ¿ø: ÀÇ»ç(Àü°øÀÇÁ¦¿Ü)- 5¸¸¿ø Àü°øÀÇ ¹× ºñÀÇ»ç- 3¸¸¿ø"
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 09:00~09:25 The importance of pancreas in diabetes Á¤Àΰæ(°æÈñÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 09:25~09:50 The role of liver in the glucose regulation À̺´¿Ï(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 09:50~10:15 Glucose toxicity and mitochondrial dysfunction in diabetes °íÀºÈñ(¿ï»êÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 10:15~10:30 Q&A ¹× ÁöÁ¤ÁúÀÇ ±è¹ÎÁö ÃÖ´öÇö Á¤Àç¿ø(°æºÏÀÇ´ë ¼øõÇâÀÇ´ë Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 10:40~11:05 Where does SGLT2i come from and where does it go in diabetes? ±è½Å°ï(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 11:05~11:30 Who are the best candidates for GLP-1 receptor agonist treatment in diabetes? ÀÓ¼ö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 11:30~11:55 What is the best strategy to prevent diabetes? Àü¼÷(°æÈñÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 11:55~12:10 Q&A ¹× ÁöÁ¤ÁúÀÇ ±è¹Î¿µ ¹ÚÁö¿ë ÁÖ»óÇö(°æ»óÀÇ´ë Àü³²ÀÇ´ë Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 13:00~13:25 From the basics of CGM in diabetes to special applications Á¶ÀçÇü(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 13:25~13:50 A solution to all problems of using an insulin pump ¹®Áؼº(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 13:50~14:15 Perfect management for type 1 diabetes ±èÀçÇö(¼º±Õ°üÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 14:15~14:30 Q&A ¹× ÁöÁ¤ÁúÀÇ ¹®ÁØÈ£ °ûÀμ± ±èÇý°æ(¼¿ïÀÇ´ë ÀüºÏÀÇ´ë ¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 14:40~15:05 DKD progression from albuminuria to dialysis ±è»ó¼ö(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 15:05~15:30 DPN from neuronal damage to clinical presentation ¿øÁ¾Ã¶(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 15:30~15:55 Heart failure from detection to management in diabetes °í°üÇ¥(Á¦ÁÖÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ 3Ãþ ¼¼°è·Î·ë 15:55~16:10 Q&A ¹× ÁöÁ¤ÁúÀÇ Á¤½Â¹Î ÀåÇѳª ¹Î¼¼Èñ(¿µ³²ÀÇ´ë ¼¿ïÀÇ´ë ¿ï»êÀÇ´ë)